Nov 14 (Reuters) - Merck & Co Inc ( MRK ):
* MERCK TO ACQUIRE CIDARA THERAPEUTICS, INC., DIVERSIFYING
ITS
PORTFOLIO TO INCLUDE LATE-PHASE ANTIVIRAL AGENT
* MERCK & CO INC ( MRK ) - TO BUY CIDARA FOR $9.2 BILLION
* MERCK ( MRK ) & CO INC PROPOSED DEAL FOR $221.50 PER SHARE IN CASH
* MERCK & CO INC ( MRK ): UNDER TERMS OF MERGER AGREEMENT, MERCK ( MRK ),
THROUGH
A UNIT, WILL ACQUIRE ALL OF OUTSTANDING SHARES OF CIDARA
Source text:
Further company coverage: